Literature DB >> 17901839

Beneficial effects of recombinant human activated protein C in a ewe model of septic shock.

Zhen Wang1, Fuhong Su, Peter Rogiers, Jean-Louis Vincent.   

Abstract

OBJECTIVE: To investigate the effects of activated protein C (APC) in a clinically relevant animal model of septic shock.
DESIGN: Prospective, randomized, controlled study.
SETTING: University medical center research laboratory.
SUBJECTS: Eighteen female sheep (body weight, 27-35 kg).
INTERVENTIONS: Animals were fasted, anesthetized, invasively monitored, and mechanically ventilated before receiving 0.5 g/kg body weight of feces intraperitoneally to induce sepsis. Fluid resuscitation with Ringer lactate was titrated to maintain pulmonary artery occlusion pressure at baseline levels. No vasoactive agents or antibiotics were used. Two hours after the induction of sepsis, animals were randomized to receive an infusion of APC (24 microg x kg(-1) x hr(-1), n = 9) or an equivalent volume of vehicle (n = 9) throughout the experimental period.
MEASUREMENTS AND MAIN RESULTS: The APC-treated animals had significantly higher arterial pressure, urine output, PaO2/FIO2 ratios, and thoracopulmonary compliance than the control animals. They had lower pulmonary arterial pressure and arterial lactate concentrations than the control animals. Plasma colloid oncotic pressure was better maintained in the APC-treated group than in the control group (p < .05). Prothrombin time and activated partial thromboplastin time were altered less, and plasma D-dimer concentrations were significantly lower in the APC-treated group than in the control group (p < .05). The blood protein C concentration and platelet count were maintained better in the APC-treated group than in the control group (p < .05). APC administration was associated with significantly longer survival (median, 27 hrs vs. 20 hrs; p < .05). At postmortem examination, the lung wet/dry ratio was significantly lower in the APC group than in the control group (6.3 +/- 0.7 vs. 7.1 +/- 1.2, p < .05).
CONCLUSIONS: In this clinically relevant model of septic shock due to fecal peritonitis, administration of APC had beneficial effects on hemodynamic variables, gas exchange, lactic acidosis, and coagulation abnormalities. Higher colloid oncotic pressures and lower lung wet/dry ratios at autopsy suggest preserved endothelial integrity. APC administration resulted in prolonged survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901839     DOI: 10.1097/01.CCM.0000287590.55294.40

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

1.  Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.

Authors:  Sebastian Rehberg; Christian Ertmer; Gabriele Köhler; Hans-Ulrich Spiegel; Andrea Morelli; Matthias Lange; Katharina Moll; Katrin Schlack; Hugo Van Aken; Fuhong Su; Jean-Louis Vincent; Martin Westphal
Journal:  Intensive Care Med       Date:  2009-04-10       Impact factor: 17.440

Review 2.  Protective mechanisms of activated protein C in severe inflammatory disorders.

Authors:  Arne P Neyrinck; Kathleen D Liu; James P Howard; Michael A Matthay
Journal:  Br J Pharmacol       Date:  2009-05-14       Impact factor: 8.739

3.  Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock.

Authors:  Marc O Maybauer; Dirk M Maybauer; John F Fraser; Csaba Szabo; Martin Westphal; Levente Kiss; Eszter M Horvath; Yoshimitsu Nakano; David N Herndon; Lillian D Traber; Daniel L Traber
Journal:  Crit Care       Date:  2010-11-26       Impact factor: 9.097

Review 4.  Year in review 2009: Critical Care--shock.

Authors:  Wolfgang Stahl; Hendrik Bracht; Peter Radermacher; Jörg Thomas
Journal:  Crit Care       Date:  2010-11-05       Impact factor: 9.097

5.  Role of selective V2-receptor-antagonism in septic shock: a randomized, controlled, experimental study.

Authors:  Sebastian Rehberg; Christian Ertmer; Matthias Lange; Andrea Morelli; Elbert Whorton; Martin Dünser; Anne-Katrin Strohhäcker; Erik Lipke; Tim G Kampmeier; Hugo Van Aken; Daniel L Traber; Martin Westphal
Journal:  Crit Care       Date:  2010-11-05       Impact factor: 9.097

6.  Inhaled aerosolised recombinant human activated protein C ameliorates endotoxin-induced lung injury in anaesthetised sheep.

Authors:  Kristine Waerhaug; Vsevolod V Kuzkov; Vladimir N Kuklin; Rica Mortensen; Kåre C Nordhus; Mikhail Y Kirov; Lars J Bjertnaes
Journal:  Crit Care       Date:  2009-04-08       Impact factor: 9.097

7.  Protein C preserves microcirculation in a model of neonatal septic shock.

Authors:  Doris Fischer; Marcel F Nold; Claudia A Nold-Petry; Antonio Furlan; Alex Veldman
Journal:  Vasc Health Risk Manag       Date:  2009-09-18

8.  Novel biomarkers for early prediction of sepsis-induced disseminated intravascular coagulation in a mouse cecal ligation and puncture model.

Authors:  Jingchun Song; Dunzhong Hu; Chao He; Tao Wang; Xuefeng Liu; Linhao Ma; Zhaofen Lin; Zili Chen
Journal:  J Inflamm (Lond)       Date:  2013-03-05       Impact factor: 4.981

Review 9.  Recombinant human activated protein C in acute lung injury: what is the role of bronchial circulation?

Authors:  Marc O Maybauer; Daniel L Traber; Dirk M Maybauer
Journal:  Crit Care       Date:  2009-01-23       Impact factor: 9.097

10.  Recombinant human activated protein C ameliorates oleic acid-induced lung injury in awake sheep.

Authors:  Kristine Waerhaug; Mikhail Y Kirov; Vsevolod V Kuzkov; Vladimir N Kuklin; Lars J Bjertnaes
Journal:  Crit Care       Date:  2008-11-20       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.